Infleqtion, Inc. (INFQ)
NYSE: INFQ · Real-Time Price · USD
12.62
-0.68 (-5.11%)
At close: Apr 28, 2026, 4:00 PM EDT
12.56
-0.06 (-0.48%)
After-hours: Apr 28, 2026, 6:58 PM EDT

Company Description

Infleqtion, Inc., designs and builds quantum computers, precision sensors, and quantum software for governments, enterprises, and research institutions.

It offers quantum computers, quantum RF systems, quantum clocks, inertial navigation solutions, glass cells, cold atom systems, ultra-cold atom systems, and accessories.

The company also provides electronic products, such as atom chip drivers, instrument control systems, coil drivers, direct digital synthesizers, and Z coil drivers.

It serves commercial and defense companies, national labs, and universities. Infleqtion, Inc. was formerly known as ColdQuanta, Inc. and changed its name to Infleqtion, Inc. in January 2026.

The company was founded in 2007 and is headquartered in Louisville, Colorado with additional offices in Chicago, Illinois; Madison, Wisconsin; Boulder, Colorado; Melbourne, Australia; and Oxford, United Kingdom.

Infleqtion, Inc.
Infleqtion logo
Country United States
Founded 2007
Industry Software - Infrastructure
Sector Technology
Employees 204
CEO Matthew Kinsella

Contact Details

Address:
3030 Sterling Circle
Boulder, Colorado 80301
United States
Phone 303-440-1284
Website infleqtion.com

Stock Details

Ticker Symbol INFQ
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002007825
CUSIP Number 45676K103
ISIN Number US45676K1034
SIC Code 7374

Key Executives

Name Position
Matthew Kinsella Founding Investor, Chief Executive Officer and Director
Dr. Dana Z. Anderson Co-Founder and Chief Science Officer
Pranav Gokhale Co-founder and Chief Technology Officer
Paul Lipman Chief Revenue Officer
Ilan Hart Chief Financial Officer
Julie A. McGee Chief Administrative Officer
Marcus L. Kupferschmidt Head of Investor Relations
Jason Hall J.D. Chief Legal Officer
Brent Schwarz Senior Vice President of Sales
Dr. Mark Saffman Chief Scientist for Quantum Information

Latest SEC Filings

Date Type Title
Apr 20, 2026 S-8 Securities to be offered to employees in employee benefit plans
Apr 10, 2026 424B3 Prospectus
Apr 9, 2026 EFFECT Notice of Effectiveness
Apr 8, 2026 8-K Current Report
Mar 31, 2026 S-1 General form for registration of securities under the Securities Act of 1933
Mar 31, 2026 8-K/A [Amend] Current report
Mar 31, 2026 8-K/A [Amend] Current report
Mar 31, 2026 10-K Annual Report
Mar 26, 2026 8-K Current Report
Mar 10, 2026 SCHEDULE 13G Filing